Your browser doesn't support javascript.
loading
Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3.
Kramerova, I; Kudryashova, E; Ermolova, N; Saenz, A; Jaka, O; López de Munain, A; Spencer, M J.
Afiliação
  • Kramerova I; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Hum Mol Genet ; 21(14): 3193-204, 2012 Jul 15.
Article em En | MEDLINE | ID: mdl-22505582
ABSTRACT
Mutations in the non-lysosomal, cysteine protease calpain 3 (CAPN3) result in the disease limb girdle muscular dystrophy type 2A (LGMD2A). CAPN3 is localized to several subcellular compartments, including triads, where it plays a structural, rather than a proteolytic, role. In the absence of CAPN3, several triad components are reduced, including the major Ca(2+) release channel, ryanodine receptor (RyR). Furthermore, Ca(2+) release upon excitation is impaired in the absence of CAPN3. In the present study, we show that Ca-calmodulin protein kinase II (CaMKII) signaling is compromised in CAPN3 knockout (C3KO) mice. The CaMK pathway has been previously implicated in promoting the slow skeletal muscle phenotype. As expected, the decrease in CaMKII signaling that was observed in the absence of CAPN3 is associated with a reduction in the slow versus fast muscle fiber phenotype. We show that muscles of WT mice subjected to exercise training activate the CaMKII signaling pathway and increase expression of the slow form of myosin; however, muscles of C3KO mice do not exhibit these adaptive changes to exercise. These data strongly suggest that skeletal muscle's adaptive response to functional demand is compromised in the absence of CAPN3. In agreement with our mouse studies, RyR levels were also decreased in biopsies from LGMD2A patients. Moreover, we observed a preferential pathological involvement of slow fibers in LGMD2A biopsies. Thus, impaired CaMKII signaling and, as a result, a weakened muscle adaptation response identify a novel mechanism that may underlie LGMD2A and suggest a pharmacological target that should be explored for therapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Calpaína / Transdução de Sinais / Cálcio / Músculo Esquelético / Distrofia Muscular do Cíngulo dos Membros / Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina / Proteínas Musculares Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Calpaína / Transdução de Sinais / Cálcio / Músculo Esquelético / Distrofia Muscular do Cíngulo dos Membros / Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina / Proteínas Musculares Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2012 Tipo de documento: Article